Encompass Health (NYSE:EHC) versus Basel Medical Group (NASDAQ:BMGL) Critical Analysis

Encompass Health (NYSE:EHC) and Basel Medical Group (NASDAQ:BMGL) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

Volatility and Risk

Encompass Health has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Basel Medical Group has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500.

Valuation and Earnings

This table compares Encompass Health and Basel Medical Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Encompass Health	$6.21 billion	2.00	$566.20 million	$6.14	20.33
Basel Medical Group	$8.90 million	0.87	-$9.50 million	N/A	N/A

Encompass Health has higher revenue and earnings than Basel Medical Group.

Analyst Ratings

This is a summary of recent ratings and target prices for Encompass Health and Basel Medical Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Encompass Health	0	2	6	1	2.89
Basel Medical Group	1	0	0	0	1.00

Encompass Health currently has a consensus price target of $148.71, indicating a potential upside of 19.13%. Given Encompass Health’s stronger consensus rating and higher possible upside, analysts plainly believe Encompass Health is more favorable than Basel Medical Group.

Insider & Institutional Ownership

97.3% of Encompass Health shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Encompass Health and Basel Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Encompass Health	10.01%	18.08%	8.22%
Basel Medical Group	N/A	N/A	N/A

Summary

Encompass Health beats Basel Medical Group on 13 of the 13 factors compared between the two stocks.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.